Continuous-flow automation and hemolysis index: a crucial combination.
A paradigm shift has occurred in the role and organization of laboratory diagnostics over the past decades, wherein consolidation or networking of small laboratories into larger factories and point-of-care testing have simultaneously evolved and now seem to favorably coexist. There is now evidence, however, that the growing implementation of continuous-flow automation, especially in closed systems, has not eased the identification of hemolyzed specimens since the integration of preanalytical and analytical workstations would hide them from visual scrutiny, with an inherent risk that unreliable test results may be released to the stakeholders. Along with other technical breakthroughs, the new generation of laboratory instrumentation is increasingly equipped with systems that can systematically and automatically be tested for a broad series of interferences, the so-called serum indices, which also include the hemolysis index. The routine implementation of these technical tools in clinical laboratories equipped with continuous-flow automation carries several advantages and some drawbacks that are discussed in this article.
Clinical Chemistry and Hematology Laboratory, Academic Hospital of Parma, Via Gramsci 14, Parma, Italy. glippi@ao.pr.it
Giuseppe
G
Lippi
Mario
M
Plebani
D001331:Automation; D019411:Clinical Laboratory Techniques / Q000379:methods*; D006461:Hemolysis; D006801:Humans